David Solomon scores an $80 million bonus. Doubt surrounded his tenure at Goldman Sachs as recently as 2023.

• 

  Goldman CEO Signs on for 5 More Years, Gets $80 Million Bonus

  The Goldman bonus vests in five years as part of a retention effort.
  
  Inc. - 1h
• 

  Goldman Sachs hands chief David Solomon $80mn retention award

  Wall Street executive’s 2024 salary also boosted by 26% to $39mn
  
  Financial Times - 9h

• Bank CEOs Jamie Dimon, David Solomon are cautious on the economy. Here’s why.

  Inflation worries remain despite strong earnings as JPMorgan Chase’s Jamie Dimon and David Solomon of Goldman Sachs weigh risks.
  
  MarketWatch - 11h

• Goldman Sachs CEO Solomon says IPO market is 'going to pick up' along with dealmaking

  At an event hosted by Cisco on Wednesday, Goldman Sachs CEO David Solomon indicated that the multi-year IPO drought should be coming to an end.
  
  CNBC - 1d
• 

  JPMorgan Chase, Wells Fargo and Goldman Sachs Report Big Profits

  The largest banks, including JPMorgan Chase, Wells Fargo and Goldman Sachs, reported bumper profits on Wednesday.
  
  The New York Times - 2d

• Goldman Sachs shares rise after topping estimates on strong trading results

  Goldman's fourth-quarter results will give investors a preview of what to expect this year, as investment banking and trading fees are both expected to rise.
  
  CNBC - 2d

• Goldman’s Solomon says US economy in a ‘fragile place’

  Wall Street bank’s chief expects deregulation under Trump to spur business investment but urges caution
  
  Financial Times - 3d
• 

  Goldman Sachs to deepen exposure to booming private credit industry

  Wall Street bank is building new unit to service and compete with private investment firms
  
  Financial Times - 4d

• Goldman’s top economist doubts Trump can make good on campaign promises

  Goldman Sachs chief economist Jan Hatzius is bullish on the outlook for the U.S. economy, in large part because he doubts Donald Trump’s incoming administration will be able to make good on its ...
  
  MarketWatch - Jan. 10

More from MarketWatch

• S&P 500 now up in 2025 after broadening rally ahead of Trump inauguration

  The U.S. stock market broadened its rally this week, with all S&P 500 sectors booking weekly gains, as investors appeared relieved by interest rates in the bond market reversing some of their ...
  
  MarketWatch - 14m

• Starbucks’s turnaround plan under new CEO now likely includes job cuts

  Coffee chain Starbucks’s promised overhaul may require cutting jobs as it tries to work more efficiently, CEO Brian Niccol said.
  
  MarketWatch - 58m

• Elon Musk once called his questions ‘boneheaded.’ What Wall Street is losing as this clear-eyed analyst retires.

  With the incoming pro-business Trump administration, Wall Street needs people willing to ask hard questions and look into whether there’s substance behind bold corporate predictions.
  
  MarketWatch - 1h

• T-bill supply will turn negative soon without a U.S. debt-limit deal: BofA

  Incoming President Donald Trump’s second administration kicks off as the U.S. debt-ceiling debate enters another critical juncture.
  
  MarketWatch - 1h

• Walgreens stock sinks after DOJ sues over illegal-prescription accusations

  The pharmacy “allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores,” the Justice Department said.
  
  MarketWatch - 1h

More in Business

• S&P 500 now up in 2025 after broadening rally ahead of Trump inauguration

  The U.S. stock market broadened its rally this week, with all S&P 500 sectors booking weekly gains, as investors appeared relieved by interest rates in the bond market reversing some of their ...
  
  MarketWatch - 14m
• 

  Israel’s full cabinet approves ceasefire deal with Hamas

  Pact to stop fighting and free hostages endorsed by Netanyahu government before going into force Sunday
  
  Financial Times - 48m

• Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

  The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
  
  CNBC - 58m

• Starbucks’s turnaround plan under new CEO now likely includes job cuts

  Coffee chain Starbucks’s promised overhaul may require cutting jobs as it tries to work more efficiently, CEO Brian Niccol said.
  
  MarketWatch - 58m

• CFPB fines Equifax $15 million over errors on credit reports

  The CFPB alleged the credit reporting bureau failed to conduct proper investigations of consumer disputes.
  
  CNBC - 1h